Emerging Biotechnology Analyst Breidenbach, along with Dr. Debosch of Washington University, discuss new treatment options for recurrent C. difficile infection on an Analyst/Industry conference call to be held on February 1 at 10 am.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on MCRB: